Association Between Inflammatory Activities and Gap Density
1 other identifier
observational
50
1 country
1
Brief Summary
The study aims to:
- 1.To determine the relationship between inflammatory activities and epithelial gaps in IBD by CLE and evaluate epithelial gaps healing via dexamethasone treatment.
- 2.To demonstrated the alteration of local barrier function in IBD using CLE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 27, 2012
CompletedFirst Posted
Study publicly available on registry
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJanuary 1, 2013
December 1, 2012
6 months
December 27, 2012
December 27, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
gap density
the distributions of gap density
6 months
Secondary Outcomes (1)
local barrier function
6 months
Study Arms (2)
Inflammatory bowel disease
Patients previously diagnosed as having IBD
Health control
Asymptomatic individuals admitted for health surveillance or patients for follow up after polypectomy.
Eligibility Criteria
Patients with indications for colonoscopy in Qilu Hospital outpatient and inpatient department.
You may qualify if:
- Male or Female aged 18-80
- IBD: Patients previously diagnosed as having IBD
- Health control: Asymptomatic individuals admitted for health surveillance or patients for follow up after polypectomy.
- Subjects who experienced successful intubation of the terminal ileum.
You may not qualify if:
- Subjects age \< 18 or \>80 years
- Subjects under conditions unsuitable for performing CLE including coagulopathy (prothrombin time \<50% of control, partial thromboplastin time \>50 s), cirrhosis, renal dysfunction (creatinine level \>1.2 mg/dL), pregnancy or breastfeeding, acute gastrointestinal bleeding, jaundice and known allergy to fluorescein sodium.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, 250012, China
Biospecimen
Observational Study Model: Case-Control
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yanqing Li, MD, PhD
Department of Gastroenterology, Qilu Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of the Department of Gastroenterology, Qilu Hospital, Shandong University
Study Record Dates
First Submitted
December 27, 2012
First Posted
January 1, 2013
Study Start
December 1, 2012
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
January 1, 2013
Record last verified: 2012-12